NantKwest

is a clinical-stage immunotherapy company that develops an innate immune system for the treatment of cancer diseases...
Read more
NantKwest CEO: Richard Adcock

CEO

Richard Adcock

CEO Approval Rating

86/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
100-250
Agree?
Funding
$366.6M
Investments
2

NantKwest Competitors

1Allogene
2Adicet Bio
3Sorrento
4Medigene
5Kite Pharma
6Puma Biotechnology
722nd Century
8JW Therapeutics
9Refuge Biotechnologies, Inc.
10Precision BioSciences

Trending Companies